Lite Strategy, Inc. (LITS)
1.04
+0.05
(+5.08%)
USD |
NASDAQ |
Aug 24, 16:00
1.07
+0.03
(+2.88%)
After-Hours: 20:00
Lite Strategy Shareholders Equity (Quarterly) : 56.84M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 56.84M |
| December 31, 2025 | 81.85M |
| September 30, 2025 | 112.27M |
| June 30, 2025 | 16.93M |
| March 31, 2025 | 19.54M |
| December 31, 2024 | 22.10M |
| September 30, 2024 | 24.88M |
| June 30, 2024 | 33.02M |
| March 31, 2024 | 51.03M |
| December 31, 2023 | 59.49M |
| September 30, 2023 | 81.36M |
| June 30, 2023 | 24.62M |
| March 31, 2023 | 34.35M |
| December 31, 2022 | 48.37M |
| September 30, 2022 | 37.31M |
| June 30, 2022 | 52.41M |
| March 31, 2022 | 67.81M |
| December 31, 2021 | 73.33M |
| September 30, 2021 | 31.83M |
| June 30, 2021 | 49.47M |
| March 31, 2021 | 44.96M |
| December 31, 2020 | 73.50M |
| September 30, 2020 | 82.33M |
| June 30, 2020 | 78.22M |
| March 31, 2020 | 74.50M |
| Date | Value |
|---|---|
| December 31, 2019 | 77.28M |
| September 30, 2019 | 47.28M |
| June 30, 2019 | 47.93M |
| March 31, 2019 | 37.88M |
| December 31, 2018 | 53.47M |
| September 30, 2018 | 39.76M |
| June 30, 2018 | 50.46M |
| March 31, 2018 | 32.91M |
| December 31, 2017 | 38.36M |
| September 30, 2017 | 43.57M |
| June 30, 2017 | 50.84M |
| March 31, 2017 | 54.90M |
| December 31, 2016 | 54.89M |
| September 30, 2016 | 42.33M |
| June 30, 2016 | 41.65M |
| March 31, 2016 | 46.91M |
| December 31, 2015 | 51.64M |
| September 30, 2015 | 55.94M |
| June 30, 2015 | 59.79M |
| March 31, 2015 | 64.96M |
| December 31, 2014 | 72.86M |
| September 30, 2014 | 37.61M |
| June 30, 2014 | 45.19M |
| March 31, 2014 | 52.52M |
| December 31, 2013 | 58.73M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| SELLAS Life Sciences Group, Inc. | 137.66M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 57.79M |
| Total Liabilities (Quarterly) | 0.952M |
| Current Ratio | 11.53 |